{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Answers from the Lab","title":"How Investment Trends May Impact Clinical Diagnostics: Bill Morice, M.D., Ph.D. ","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/de2417d7\"></iframe>","width":"100%","height":180,"duration":752,"description":"In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, discuss summertime illnesses and key insights from a recent diagnostic investment event. Together, they explore:\nCommon summertime illnesses, along with tips for prevention. \nHow investment in diagnostic tools influences innovation in the laboratory.\nThe potential impact of growing interest in AI investments. \nThe investment interest in liquid biopsy and its potential implications for clinical decision-making.\nHow AI development may accelerate adoption of mass spectrometry, proteomics, and similar advancements in clinical laboratories. ","thumbnail_url":"https://img.transistorcdn.com/jhRCftFebxnTMwoIbA_WoqrSKwFRD_Y2kbh0JDjhx14/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjNj/ZDc0NTE0MWNlOWRl/YzRiN2Q3NDg2Mjg5/YWE4MS5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}